多层面质量改进干预对中国急性缺血性卒中患者绩效指标依从性的随机临床试验
该多中心整群随机临床试验纳入中国40家公立医院的4800例急性缺血性卒中患者,评估多层面质量改进干预(临床路径、护理方案、质量协调员监督、绩效监测反馈)与常规注册对照相比,对医院人员依从9项循证绩效指标的影响。干预组3、6、12个月新发血管事件显著减少。
要点
- 多层面质量改进干预小幅但显著提高复合绩效指标依从率(绝对差3.54%)。
- 干预组3、6、12个月新发临床血管事件均显著低于对照组。
核心结论
- 多层面质量改进干预相比常规护理,在复合绩效指标上显著但小幅改善医院人员对急性缺血性卒中循证绩效指标的依从性,全或无指标未达显著差异。
- 干预组3、6、12个月新发临床血管事件显著减少,需进一步研究了解结果的普适性。
研究设计与样本
- 多中心整群随机临床试验,纳入中国40家公立医院,2014年8月10日至2015年6月20日入组4800例急性缺血性卒中住院患者,随访12个月至2016年7月30日。
- 20家医院接受多层面质量改进干预(干预组2400例),20家医院参与卒中注册并接受常规护理(对照组2400例)。
关键数值与推荐
- 主要结局为医院人员对9项急性缺血性卒中绩效指标的依从性,共同主要结局为依从绩效指标百分比复合评分和全或无评分。
- 次要结局包括院内死亡率及3、6、12个月长期结局(新发血管事件、残疾[改良Rankin量表评分3-5]、全因死亡)。
临床怎么用
- 多层面质量改进干预(临床路径、护理方案、质量协调员监督、绩效监测反馈)可作为改善急性缺血性卒中循证绩效指标依从性的策略。
- 干预可能降低新发临床血管事件风险,但复合指标改善幅度较小,全或无依从性未显著改善。
局限性
- 结果普适性需进一步研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In China and other parts of the world, hospital personnel adherence to evidence-based stroke care is limited. OBJECTIVE: To determine whether a multifaceted quality improvement intervention can improve hospital personnel adherence to evidence-based performance measures in patients with acute ischemic stroke (AIS) in China. DESIGN, SETTING, AND PARTICIPANTS: A multicenter, cluster-randomized clinical trial among 40 public hospitals in China that enrolled 4800 patients hospitalized with AIS from August 10, 2014, through June 20, 2015, with 12-month follow-up through July 30, 2016. INTERVENTIONS: Twenty hospitals received a multifaceted quality improvement intervention (intervention group; 2400 patients), including a clinical pathway, care protocols, quality coordinator oversight, and performance measure monitoring and feedback. Twenty hospitals participated in the stroke registry with usual care (control group; 2400 patients). MAIN OUTCOMES AND MEASURES: The primary outcome was hospital personnel adherence to 9 AIS performance measures, with co-primary outcomes of a composite of percentage of performance measures adhered to, and as all-or-none. Secondary outcomes included in-hospital mortality and long-term outcomes (a new vascular event, disability [modified Rankin Scale score, 3-5], and all-cause mortality) at 3, 6, and 12 months. RESULTS: Among 4800 patients with AIS enrolled from 40 hospitals and randomized (mean age, 65 years; women, 1757 [36.6%]), 3980 patients (82.9%) completed the 12-month follow-up of the trial. Patients in intervention group were more likely to receive performance measures than those in the control groups (composite measure, 88.2% vs 84.8%, respectively; absolute difference, 3.54% [95% CI, 0.68% to 6.40%], P = .02). The all-or-none measure did not significantly differ between the intervention and control groups (53.8% vs 47.8%, respectively; absolute difference, 6.69% [95% CI, -0.41% to 13.79%], P = .06). New clinical vascular events were significantly reduced in the intervention group compared with the control group at 3 months (3.9% vs 5.3%, respectively; difference, -2.03% [95% CI, -3.51% to -0.55%]; P = .007), 6 months (6.3% vs 7.8%, respectively; difference, -2.18% [95% CI, -4.0% to -0.35%]; P = .02) and 12 months (9.1% vs 11.8%, respectively; difference, -3.13% [95% CI, -5.28% to -0.97%]; P = .005). CONCLUSIONS AND RELEVANCE: Among 40 hospitals in China, a multifaceted quality improvement intervention compared with usual care resulted in a statistically significant but small improvement in hospital personnel adherence to evidence-based performance measures in patients with acute ischemic stroke when assessed as a composite measure, but not as an all-or-none measure. Further research is needed to understand the generalizability of these findings. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02212912.
引用
- Wang Y, Li Z, Zhao X, et al. Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial. JAMA. 2018. PMID: 29959443. doi:10.1001/jama.2018.8802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。